The Journal of Steroid Biochemistry and Molecular Biology
Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase☆
Introduction
The 17β-hydroxysteroid dehydrogenases (17β-HSDs) are enzymes involved in the formation of active sex steroids, namely testosterone (T), estradiol (E2), 5-androstenediol (5-diol) and dihydrotestosterone (DHT). They catalyze the last and key step in the formation of all estrogens and androgens since sex steroids require the presence of a hydroxy group at position 17β on the steroid nucleus. The most widely known is the testicular enzyme, which catalyzes the transformation of 4-androstenedione (4-dione) into testosterone (T) [1]. Its impairment in the male embryo leads to male pseudohermaphroditism characterized by the absence of the male internal reproductive structures (epididymis, seminal vesicles and vas deferens) that are normally formed from Wolffian ducts under the control of T. Because of the existence of multiple diseases due to the deficiency of gonadal sex steroid production and the belief that steroids were freely distributed through blood circulation, it was generally believed until recently that sex steroids were produced exclusively by the gonads. However, this belief was proven wrong by studies performed in men who had their testicles removed or their testicular androgen secretion totally blocked by a treatment with an agonist of luteinizing hormone-releasing hormone (LHRH, see [2], [3] for reviews). It was found that, while their testosterone blood level was reduced by 90–95% following castration, their intraprostatic concentration of DHT was decreased by only 50%, thus, suggesting an intraprostatic biosynthesis of androgens. The development of secondary sexual characters in young boys deficient in the type 2 3β-HSD is a natural proof of the conversion of adrenal precursors dehydroepiandrosterone (DHEA) into active sex steroids in target tissues. In recent years, the existence of a local biosynthesis of sex steroids in peripheral tissues was further confirmed by the cloning of multiple types of steroidogenic enzymes, namely type 1 and 2 3β-HSD [4], [5], [6], [7], [8], type 1 [9], type 2 [10], [11], type 3 [12], type 5 [13] and type 7 [14] 17β-HSD as well as type 1 [15], [16] and type 2 [17], [18] 5α-reductases. The expression of these enzymes is tissue-specific, some being expressed only in peripheral tissues. Furthermore, it has been clearly demonstrated that certain congenital diseases are due to a deficiency in a single form of an enzyme. For example, a deficiency in type 2 3β-HSD [19], [20] is responsible for congenital adrenal hyperplasia; a deficiency of type 2 5α-reductase [21] and/or type 3 17β-HSD [12] causes male pseudohermaphroditism. This supports strongly the finding that peripheral tissues possess their own steroidogenic enzymes responsible for an independent biosynthesis of androgens and estrogens from DHEA and/or its sulfate (DHEAS). These precursors are secreted by the adrenals of humans and a few other primates but not in animals of the lower species.
Section snippets
Multiple 17β-HSDs and intracrinology
The formation of estradiol (E2) from estrone (E1), of T from 4-dione, of 5-androstene-3β,17β-diol (5-diol) from DHEA, of DHT from 5α-androstane-3,17-dione (A-dione) and their respective reverse reactions are catalyzed by 17β-HSDs (Fig. 1), which are distributed widely in human tissues. In fact, 17β-HSD activity is not only present in classical steroidogenic tissues, such as the human placenta [9], [22], ovary [23], and testis [1], [12], but also in a large series of peripheral intracrine
Unidirectional activity of 17β-HSDs
By analogy to almost all other dehydrogenases, 17β-hydroxysteroid dehydrogenases were until recently considered to be reversible enzymes that catalyze the interconversion of substrates and products, mainly because they were first characterized using tissue homogenates or subfractions or purified proteins with added oxidized (NAD+/NADP+) or reduced (NADH/NADPH) cofactors. These exogenous cofactors drive the reaction in the oxidative or reductive direction depending upon their oxidized or reduced
Local control of estrogen and androgen formation and inactivation by 17β-HSDs
It is well recognized that sex steroids play a predominant role in the regulation of cell growth and differentiation of the normal prostate and mammary gland, as well as in hormone-sensitive prostate and breast carcinomas. It is generally accepted that, while estrogens stimulate the proliferation of hormone-sensitive breast cancer cells [67], [68], [69], [70], androgens exert an antiproliferative action on these cells [67], [71], [72], [73].
In the case of hormones provided to the cells from
Differential characteristics of 17β-HSDs of human and laboratory animals
The characteristics of 17β-HSDs and other steroidogenic enzymes of rodents are different from those of their human counterparts. Indeed, while human type 1 17β-HSD is selective for the transformation of E1 into E2 [45], the mouse enzyme also transforms C19-steroids [76]. Human type 5 17β-HSD is highly labile upon homogenization of the cells. In contrast, the mouse enzyme is stable and is not altered by homogenization [13]. Most importantly, they also show different substrate specificity
Divergence of different types of 17β-HSD on the evolutionary scale
Within a given species, the different types of 17β-HSDs share very low homology (approximately 20%) but catalyze closely the related activities, they catalyze the oxidation and/or reduction of the oxygen atom located at position 17 of the steroid nucleus. However, orthologs of each type can be formed in other species at the normal percentage of homology for orthologs. In contrast, different types of human 3β-HSD and aldo–keto reductases are highly homologous. Their percentage of identity could
Acknowledgements
This work was supported by grants from Medical Research Council of Canada and Endorecherche, Inc.
References (82)
- et al.
Testicular 17β-hydroxysteroid dehydrogenase: molecular properties and reaction mechanism
Steroids
(1986) - et al.
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival
J. Steroid Biochem.
(1985) - et al.
Characterization of human 3β-hydroxysteroid dehydrogenase/Δ5–Δ4 isomerase gene and its expression in mammalian cells
J. Biol. Chem.
(1990) - et al.
Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity
J. Biol. Chem.
(1993) - et al.
Determination of cDNA, gene structure and chromosomal localization of the novel human 17β-hydroxysteroid dehydrogenase type 7(1)
FEBS Lett.
(1999) - et al.
Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue
Genomics
(1991) - et al.
Human placental 17β-estradiol dehydrogenase. V. Purification and partial characterization of the diphosphopyridine nucleotide (triphosphopyridine nucleotide)-linked enzyme
J. Biol. Chem.
(1970) - et al.
Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues
J. Steroid Biochem. Mol. Biol.
(1992) - et al.
In vitro interconversion of estrone and 17β-estradiol in human skin and vaginal mucosa
J. Invest. Dermatol.
(1968) - et al.
17β-Hydroxysteroid dehydrogenase from human red blood cells
J. Biol. Chem.
(1968)
Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells
J. Steroid Biochem. Mol. Biol.
Some characteristics of 17β-estradiol dehydrogenase from bovine placenta
Steroids
Purification of rat testicular microsomal 17-ketosteroid reductase. Evidence that 17-ketosteroid reductase and 17β-hydroxysteroid dehydrogenase are distinct enzymes
J. Biol. Chem.
Metabolism of estradiol in isolated perfused rat lungs
J. Steroid Biochem.
Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/Δ5–Δ4 isomerase (3β-HSD), 17β-HSD 5α-reductase and aromatase activities in the rhesus monkey
Mol. Cell. Endocrinol.
Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA
FEBS Lett.
Expression of human 17β-hydroxysteroid dehydrogenase in mammalian cells
J. Steroid Biochem. Mol. Biol.
Subunit identity of the dimeric 17β-hydroxysteroid dehydrogenase from human placenta
J. Biol. Chem.
Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.20 A resolution
Structure
Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases
J. Biol. Chem.
Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate
J. Biol. Chem.
Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor
J. Biol. Chem.
Physical mapping 220 kb centromeric of the human MHC and DNA sequence analysis of the 43-kb segment including the RING1, HKE6, and HKE4 genes
Genomics
Characterization of Ke 6, a new 17β-hydroxysteroid dehydrogenase, and its expression in gonadal tissues
J. Biol. Chem.
Characteristics of human types 1, 2, and 3 17β-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition
J. Steroid Biochem. Mol. Biol.
A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis
J. Steroid Biochem. Mol. Biol.
Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues
Eur. J. Cancer Clin. Oncol.
Molecular cloning of a chiral-specific 3α-hydroxysteroid sulfotransferase
J. Biol. Chem.
Structure of the human type II 3β-hydroxysteroid dehydrogenase/Δ5–Δ4 isomerase (3β-HSD) gene: adrenal and gonadal specificity
DNA Cell Biol.
Human 3β-hydroxysteroid dehydrogenase/Δ5–Δ4 isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids
Endocrinology
Structural analysis of the gene encoding human 3β-hydroxysteroid dehydrogenase/Δ5–Δ4-isomerase
Mol. Endocrinol.
Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5–Δ4-isomerase in human adrenals and gonads
Mol. Endocrinol.
Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes
Mol. Endocrinol.
The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species
DNA Cell Biol.
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Nat. Genet.
Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase
Endocrinology
Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases
Proc. Natl. Acad. Sci. USA
Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
Nature
Structure of human type II 5α-reductase gene
Endocrinology
Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene
Nat. Genet.
Cited by (228)
Psoralen prevents the inactivation of estradiol and treats osteoporosis via covalently targeting HSD17B2
2023, Journal of Ethnopharmacology16-Picolyl-androsterone derivative exhibits potent 17β-HSD3 inhibitory activity, improved metabolic stability and cytotoxic effect on various cancer cells: Synthesis, homology modeling and docking studies
2021, Journal of Steroid Biochemistry and Molecular BiologyJapanese eel retinol dehydrogenases 11/12-like are 17-ketosteroid reductases involved in sex steroid synthesis
2021, General and Comparative Endocrinology
- ☆
Proceedings of the 14th International Symposium of the Journal of Steroid Biochemistry and Molecular Biology “Recent Advances in Steroid Biochemistry and Molecular Biology” (Quebec, Canada 24–27 June, 2000).